June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Retinal changes in Hemiparkinson rat
Author Affiliations & Notes
  • Soon Il Kwon
    ophthalmology, HALLYM Sacred heart HOSPITAL, Hallym University, Anyang, Republic of Korea
  • Chul Bum Cho
    neurosurgery, HALLYM Sacred heart HOSPITAL, Hallym University, Anyang, Republic of Korea
  • In-Beom Kim
    Anatomy, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
  • Footnotes
    Commercial Relationships Soon Il Kwon, None; Chul Bum Cho, None; In-Beom Kim, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 6070. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Soon Il Kwon, Chul Bum Cho, In-Beom Kim; Retinal changes in Hemiparkinson rat. Invest. Ophthalmol. Vis. Sci. 2013;54(15):6070.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

Parkinson’s disease (PD) is a progressive, multisystem neurodegenerative disorder and dopamine deficiency of the nigrostriatal system is still regarded as the major problem. Visual symptoms are common in PD, ranging from complaints of dry eyes and reading difficulties, through to perceptual disturbances and complex visual hallucinations. Dopaminergic deficiency with loss of a subset of retinal amacrine cells were reported in various PD animal models. However, there are few studies about retinal changes in animal PD model using 6-hydroxydopamine(6-OHDA). Therefore current study investigates the retinal changes in unilateral 6-OHDA-induced rat model of PD

 
Methods
 

PD rat model was established by injection of 6-OHDA into right substantia nigra. . At 2 weeks after surgery, only animals passed the rotation test were included in model group and compared with normal control group. Retinal tissue was collected in ipsilateral and contralateral eye of PD model group and either eye in control group and prepared for immunohistochemistry. The antibodies applied in immunohistochemistry were anti-TH(1:1000), anti-b-NOS(1:5000), anti parvalbumin (1:1000), calbindin(1:2000), and anti PKC-A (1:1000).

 
Results
 

The number of dopaminergic amacrine neurons was significantly decreased in ipsilateral and contralateral retina compared to control. The immunoreativities seen at the border of outer plexiform layer and inner plexiform layer were also decreased in both eyes of PD model compared to control model. AII amacrine neurons and rod bipolar cells in both eyes in PD model showed irregular arrangement and loss of axons in immunohistochemistry using parvalbumin and PKC-a, respectively.

 
Conclusions
 

In hemiparkinson animal model using 6-OHDA, both ipsilateral and contralateral retinas showed structural and functional changes involving dopaminergic amacrine cells, AII amacrine cells and rod bipolar cells.

 
 
Dopaminergic amacrine cells(DA) expressing anti-TH(tyrosine hydoxylase) in control group. Bright processes throughout the entire inner plexiform layer(IPL, dotted arrow)and outer plexiform layer (OPL, solid arrow)
 
Dopaminergic amacrine cells(DA) expressing anti-TH(tyrosine hydoxylase) in control group. Bright processes throughout the entire inner plexiform layer(IPL, dotted arrow)and outer plexiform layer (OPL, solid arrow)
 
 
Dopaminergic amacrine cells(DA) expressing anti-TH(tyrosine hydoxylase) in Parkinson model. The cell size of DA is slightly smaller than control group. Decreased immunoreactivities are noted in inner and outer plexiform layer
 
Dopaminergic amacrine cells(DA) expressing anti-TH(tyrosine hydoxylase) in Parkinson model. The cell size of DA is slightly smaller than control group. Decreased immunoreactivities are noted in inner and outer plexiform layer
 
Keywords: 637 pathology: experimental • 695 retinal degenerations: cell biology  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×